Other
Pad test
Pad test is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Other(2)
Detailed Status
unknown2
Completed2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
unknown250%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
unknown
To Use the Combined Version of ICIQ-SF and Quality of Life Scale in Mixed Urinary Incontinence
NCT05948397
unknownnot_applicable
Stress Urinary Incontinence in Elite Athletes
NCT03938779
completed
BOO and DU and Their Clinical and Urodynamic Findings in Women With ≥Stage II Cystocele
NCT03613324
completed
Prevalence Rates of USI, BO, DO and Their Clinical and Urodynamic Findings in Women With ≥Stage II Cystocele
NCT03613350
Clinical Trials (4)
Showing 4 of 4 trials
NCT05948397
To Use the Combined Version of ICIQ-SF and Quality of Life Scale in Mixed Urinary Incontinence
NCT03938779Not Applicable
Stress Urinary Incontinence in Elite Athletes
NCT03613324
BOO and DU and Their Clinical and Urodynamic Findings in Women With ≥Stage II Cystocele
NCT03613350
Prevalence Rates of USI, BO, DO and Their Clinical and Urodynamic Findings in Women With ≥Stage II Cystocele
All 4 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 4